Drug Shortage Report for SANDOZ SILODOSIN
Report ID | 188665 |
Drug Identification Number | 02475448 |
Brand name | SANDOZ SILODOSIN |
Common or Proper name | SILODOSIN |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | SILODOSIN |
Strength(s) | 8MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100HGC |
ATC code | G04CA |
ATC description | DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-04-04 |
Estimated end date | 2023-07-14 |
Actual end date | 2023-07-17 |
Shortage status | Resolved |
Updated date | 2023-07-18 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2023-07-18 | English | Compare |
v9 | 2023-07-17 | French | Compare |
v8 | 2023-07-17 | English | Compare |
v7 | 2023-05-15 | French | Compare |
v6 | 2023-05-15 | English | Compare |
v5 | 2023-05-08 | French | Compare |
v4 | 2023-05-08 | English | Compare |
v3 | 2023-04-05 | English | Compare |
v2 | 2023-04-04 | French | Compare |
v1 | 2023-04-04 | English | Compare |
Showing 1 to 10 of 10